Lv2
110 积分 2023-02-01 加入
BCMA-CD19 compound CAR T cells for systemic lupus erythematosus: a phase 1 open-label clinical trial
1天前
已完结
Recognizing, defining, and managing CAR-T hematologic toxicities
8个月前
已完结
Global prevalence of human papillomavirus-related oral and oropharyngeal squamous cell carcinomas: a systematic review and meta-analysis
8个月前
已完结
Clinical outcomes of oropharyngeal squamous cell carcinoma stratified by human papillomavirus subtype: A systematic review and meta-analysis
8个月前
已完结
Prevention and management of adverse events during treatment with bispecific antibodies and CAR T cells in multiple myeloma: a consensus report of the European Myeloma Network
10个月前
已完结
Apatinib as second-line or later therapy in patients with advanced hepatocellular carcinoma (AHELP): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial
10个月前
已完结
Hematologic cytopenia post CAR T cell therapy: Etiology, potential mechanisms and perspective
1年前
已完结
Camrelizumab in patients with previously treated advanced hepatocellular carcinoma: a multicentre, open-label, parallel-group, randomised, phase 2 trial
1年前
已完结
The Efficacy and Safety of Ramucirumab in Heavily Pretreated Advanced Hepatocellular Carcinoma
1年前
已完结
Immunotherapy combination with regorafenib for refractory hepatocellular carcinoma: A real-world study
1年前
已完结
皖公网安备34019202002308
